Patients with active MM (N = 347) | Patients without active MM (n = 176) | P value | ||||
---|---|---|---|---|---|---|
eGFR > 55 (n = 266) | Median k sFLC (IQR) mg/L | 21,35 (10,45-103,25) | eGFR > 55 (n = 146) | Median k sFLC (IQR) mg/L | 15,8 (11,14-24,85) | < 0.001 |
Median λ sFLC (IQR) mg/L | 10,45 (6–23,9) | Median λ sFLC (IQR) mg/L | 15,2 (11,15-21,02) | 0.001 | ||
Median sFLC ratio (IQR) | 2,2 (0,53-14,88) | Median sFLC ratio (IQR) | 1,09 (0,87-1,34) | < 0.001 | ||
EGFR ≤ 55 (n = 81) | Median k sFLC (IQR) mg/L | 57,7 (15,35–815) | EGFR ≤ 55 (n = 30) | Median k sFLC (IQR) mg/L | 55,35 (35,47-94,15) | 0,001 |
Median λ sFLC (IQR) mg/L | 17,7 (7,9–149) | Median λ sFLC (IQR) mg/L | 35,95 (22,62-62,02) | < 0,001 | ||
Median sFLC ratio (IQR) | 5,34 (0,107-71,76) | Median sFLC ratio (IQR) | 1,31 (0,95-2,08) | 0,001 | ||
Creatinine mg/dL (IQR) | 1,6 (1,24-2,68) | Creatinine mg/Dl (IQR) | 2,11 (1,43-2,98) | 0,108 | ||
eGFR (IQR) | 39 (19,5–49) | eGFR (IQR) | 28,8 (19,6-50,5) | 0,429 |